v3.21.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenues $ 9,297 $ 6,301
Cost of Revenues 2,613 1,609
Gross Profit 6,684 4,692
Operating Expenses    
Research and development 6,523 3,893
Sales and marketing 5,331 3,043
General and administrative 15,261 13,660
Acquisition-related costs 1,057 1,277
Amortization of intangibles 2,306 3,629
Total Operating Expenses 30,478 25,502
Loss from Operations (23,794) (20,810)
Other Expense    
Interest expense, net (2,426) (2,277)
Loss on exchange of debt for equity (210) (294)
Provision for valuation allowance on related party loan - held for sale (2,370) (10,627)
Other expense (470) (558)
Total Other Expense (5,476) (13,756)
Net Loss, before tax (29,270) (34,566)
Income tax benefit 56 584
Net Loss (29,214) (33,982)
Net Income Attributable to Non-controlling Interest 15 9
Net Loss Attributable to Stockholders of Inpixon (29,229) (33,991)
Deemed dividend for triggering of warrant down round feature 0 (1,250)
Net Loss Attributable to Common Stockholders $ (29,229) $ (35,241)
Net Loss Per Basic and Diluted Common Share    
Net Loss Per Share - Basic and Diluted (in usd per share) $ (1.01) $ (47.52)
Weighted Average Shares Outstanding    
Basic and Diluted (in shares) 28,800,493 741,530

Source